Drug intelligence / Profile preview

2-(thiomethylene)-4-methylpentanoic acid

Development stage: Unknown
Modality: Small Molecules

Overview

2-(Thiomethylene)-4-methylpentanoic acid is a synthetic small molecule with the molecular formula C7H14O2S and a molecular weight of 162.25 g/mol[1][3]. It is also known by its IUPAC name, (2S)-4-methyl-2-(sulfanylmethyl)pentanoic acid[1][2]. The compound is classified as an experimental drug and does not have any approved indications or clinical trial activity reported in major databases as of June 2025[3]. There are no details available regarding its mechanism of action, pharmacology, or therapeutic use in humans. It has been referenced under several chemical identifiers including DrugBank ID DB02996 and PubChem CID 17754166[1][3].

Other names: (2S)-4-methyl-2-(sulfanylmethyl)pentanoic acid(R)-RETRO-THIORPHAN

Beyond the preview

Go deeper on 2-(thiomethylene)-4-methylpentanoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-(thiomethylene)-4-methylpentanoic acid.

Explore the full profile